首页> 美国卫生研究院文献>other >The intestinal epithelial barrier: A therapeutic target?
【2h】

The intestinal epithelial barrier: A therapeutic target?

机译:肠上皮屏障:治疗目标?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A fundamental function of the intestinal epithelium is to act as a barrier that regulates interactions between the luminal contents, such as the intestinal microbiota, the underlying immune system, and the remainder of the body, while supporting vectorial transport of nutrients, water, and waste products. Epithelial barrier function requires a contiguous layer of cells as well as the junctions that seal the paracellular space between epithelial cells. Compromised intestinal barrier function has been associated with a number of disease states, both intestinal and systemic. Unfortunately, most current clinical data are correlative, making it difficult to separate cause from effect in interpreting significance of barrier loss. Some data from experimental animal models suggest that compromised epithelial integrity may play a pathogenic role in specific gastrointestinal diseases, but no FDA-approved therapies for targeting the epithelial barrier are presently available. In order for this goal to be achieved, a deeper understanding of both disease pathogenesis and mechanisms of barrier regulation must be reached.
机译:肠上皮细胞的基本功能是充当屏障,调节管腔内容物(例如肠微生物群),潜在的免疫系统与身体其余部分之间的相互作用,同时支持营养素,水和废物的矢量运输产品。上皮屏障功能需要细胞的连续层以及密封上皮细胞之间细胞旁空间的连接。肠道屏障功能受损与肠道和全身性许多疾病状态相关。不幸的是,大多数最新的临床数据是相关的,因此在解释屏障丧失的重要性时很难将原因与效果分开。来自实验动物模型的一些数据表明,受损的上皮完整性可能在特定的胃肠道疾病中发挥致病作用,但目前尚无FDA批准的靶向上皮屏障的疗法。为了实现这一目标,必须对疾病的发病机理和屏障调节机制有更深入的了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号